DK0680333T3 - Forebyggelse og behandling af cytomegalovirus ved hjælp af aminopeptidase - Google Patents

Forebyggelse og behandling af cytomegalovirus ved hjælp af aminopeptidase

Info

Publication number
DK0680333T3
DK0680333T3 DK94906142T DK94906142T DK0680333T3 DK 0680333 T3 DK0680333 T3 DK 0680333T3 DK 94906142 T DK94906142 T DK 94906142T DK 94906142 T DK94906142 T DK 94906142T DK 0680333 T3 DK0680333 T3 DK 0680333T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
cytomegalovirus
aminopeptidase
aminopeptidases
Prior art date
Application number
DK94906142T
Other languages
English (en)
Inventor
John A Zaia
Terrence Giugni
Erna Miller
Cecilia Siderberg
Original Assignee
Erna Miller
Cecilia Siderberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erna Miller, Cecilia Siderberg filed Critical Erna Miller
Application granted granted Critical
Publication of DK0680333T3 publication Critical patent/DK0680333T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/005Enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813Exopeptidases (3.4.11. to 3.4.19)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687Chemical treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
DK94906142T 1993-01-21 1994-01-21 Forebyggelse og behandling af cytomegalovirus ved hjælp af aminopeptidase DK0680333T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US698293A 1993-01-21 1993-01-21
US9966493A 1993-07-30 1993-07-30
PCT/EP1994/000188 WO1994016724A1 (en) 1993-01-21 1994-01-21 Prevention and treatment of cytomegalovirus using aminopeptidase

Publications (1)

Publication Number Publication Date
DK0680333T3 true DK0680333T3 (da) 2000-01-03

Family

ID=26676317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906142T DK0680333T3 (da) 1993-01-21 1994-01-21 Forebyggelse og behandling af cytomegalovirus ved hjælp af aminopeptidase

Country Status (11)

Country Link
US (1) US6511662B1 (da)
EP (1) EP0680333B1 (da)
JP (1) JPH08506106A (da)
AT (1) ATE179613T1 (da)
AU (1) AU681115B2 (da)
CA (1) CA2154346A1 (da)
DE (1) DE69418307T2 (da)
DK (1) DK0680333T3 (da)
ES (1) ES2131188T3 (da)
GR (1) GR3030462T3 (da)
WO (1) WO1994016724A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527489A (ja) * 1998-10-22 2002-08-27 キュラゲン コーポレイション 腎疾患および関連疾患に対する予想および治療的遺伝子およびタンパク質
RU2272645C2 (ru) * 2004-01-19 2006-03-27 Светлана Николаевна Козлова Способ лечения цмв-инфекции у детей раннего возраста
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
GB0803076D0 (en) * 2008-02-20 2008-03-26 Univ Ghent Mucosal Membrane Receptor and uses thereof
DK2352759T3 (da) 2008-07-16 2017-12-18 Inst Res Biomedicine Antistoffer, der neutraliserer humant cytomegalovirus, og anvendelse deraf

Also Published As

Publication number Publication date
EP0680333B1 (en) 1999-05-06
DE69418307T2 (de) 1999-11-04
AU681115B2 (en) 1997-08-21
AU5999194A (en) 1994-08-15
CA2154346A1 (en) 1994-08-04
DE69418307D1 (de) 1999-06-10
EP0680333A1 (en) 1995-11-08
JPH08506106A (ja) 1996-07-02
GR3030462T3 (en) 1999-10-29
ES2131188T3 (es) 1999-07-16
US6511662B1 (en) 2003-01-28
ATE179613T1 (de) 1999-05-15
WO1994016724A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
BG100455A (en) Hiv protease inhibitors
DK57391A (da) Hiv proteiner og peptider til anvendelse ved diagnosticering, profylakse og behandling af aids
NO994639L (no) Antimikrobiell forebyggelse og behandling av humant immundeficiensvirus og andre infektiöse sykdommer
NO905428L (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
ATE230757T1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
SE8602981D0 (sv) Novel medicinal use
EP0853662A4 (en) NEW REPLICABLE HUMAN IMMUNE WEAKNESS VIRUS TYPE II (HIV-2) PROVIRAL CLONE HIV-2KR
KR950700761A (ko) 사람 면역결핍 바이러스(HIV) 감염의 예방 및 치료를 위한 재조합 사람 HIV-중화 모노클로날 항체(Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection)
DK0680333T3 (da) Forebyggelse og behandling af cytomegalovirus ved hjælp af aminopeptidase
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
EP0821965A3 (de) Verwendung von (Meth)arcylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
NO962259L (no) Anvendelse av dimeticon for behandling av aphthae og stomatitt
AU9495098A (en) Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection
ZA972722B (en) Method for prevention and treatment of viral infectious diseases.
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
DE3874606D1 (de) Behandlung von viraler infektion.
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection